Request for Covid-19 Impact Assessment of this Report

Healthcare

Covid-19 Impact on Guaifenesin Market , Global Research Reports 2020-2021

  • BMR3856508
  • 99 Pages
  • May 2020
  • Healthcare
Download Sample    Get Discount   
 
This report provides a complete quantitative data and qualitative analysis on the global market for Guaifenesin. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.

Prior to COVID-19, the global market for Guaifenesin was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Guaifenesin is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.

This report covers market size and forecasts of Guaifenesin, including the following market information:

Global Guaifenesin Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)

Global Guaifenesin Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)

Global Guaifenesin Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)

Global Guaifenesin Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

Key market players

Major competitors identified in this market include Granules, Synthokem Labs, Haizhou Pharma, Yuan Cheng Group, Stellar Chemical, Biesterfeld, Seven Star Pharma, Camlin Fine Science, Gennex Lab, Iwaki Seiyaku, Pan Drugs, Delta Synthetic, Smart Pharm, etc.

Based on the Region:

Asia-Pacific (China, Japan, South Korea, India and ASEAN)

North America (US and Canada)

Europe (Germany, France, UK and Italy)

Rest of World (Latin America, Middle East & Africa)

Based on the Type:

98%-99%

Above 99%

Based on the Application:

Pharmaceuticals

Personal Care Products

Others

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Guaifenesin Industry

1.7 COVID-19 Impact: Guaifenesin Market Trends

2 Global Guaifenesin Quarterly Market Size Analysis

2.1 Guaifenesin Business Impact Assessment - COVID-19

2.1.1 Global Guaifenesin Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Guaifenesin Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Guaifenesin Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Guaifenesin Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Guaifenesin Factory Price by Manufacturers

3.3 Location of Key Manufacturers Guaifenesin Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Guaifenesin Market

3.5 Key Manufacturers Guaifenesin Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Guaifenesin Segments, By Type

4.1 Introduction

1.4.1 98%-99%

1.4.2 Above 99%

4.2 By Type, Global Guaifenesin Market Size, 2019-2021

4.2.1 By Type, Global Guaifenesin Market Size by Type, 2020-2021

4.2.2 By Type, Global Guaifenesin Price, 2020-2021

5 Impact of Covid-19 on Guaifenesin Segments, By Application

5.1 Overview

5.5.1 Pharmaceuticals

5.5.2 Personal Care Products

5.5.3 Others

5.2 By Application, Global Guaifenesin Market Size, 2019-2021

5.2.1 By Application, Global Guaifenesin Market Size by Application, 2019-2021

5.2.2 By Application, Global Guaifenesin Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Granules

7.1.1 Granules Business Overview

7.1.2 Granules Guaifenesin Quarterly Production and Revenue, 2020

7.1.3 Granules Guaifenesin Product Introduction

7.1.4 Granules Response to COVID-19 and Related Developments

7.2 Synthokem Labs

7.2.1 Synthokem Labs Business Overview

7.2.2 Synthokem Labs Guaifenesin Quarterly Production and Revenue, 2020

7.2.3 Synthokem Labs Guaifenesin Product Introduction

7.2.4 Synthokem Labs Response to COVID-19 and Related Developments

7.3 Haizhou Pharma

7.3.1 Haizhou Pharma Business Overview

7.3.2 Haizhou Pharma Guaifenesin Quarterly Production and Revenue, 2020

7.3.3 Haizhou Pharma Guaifenesin Product Introduction

7.3.4 Haizhou Pharma Response to COVID-19 and Related Developments

7.4 Yuan Cheng Group

7.4.1 Yuan Cheng Group Business Overview

7.4.2 Yuan Cheng Group Guaifenesin Quarterly Production and Revenue, 2020

7.4.3 Yuan Cheng Group Guaifenesin Product Introduction

7.4.4 Yuan Cheng Group Response to COVID-19 and Related Developments

7.5 Stellar Chemical

7.5.1 Stellar Chemical Business Overview

7.5.2 Stellar Chemical Guaifenesin Quarterly Production and Revenue, 2020

7.5.3 Stellar Chemical Guaifenesin Product Introduction

7.5.4 Stellar Chemical Response to COVID-19 and Related Developments

7.6 Biesterfeld

7.6.1 Biesterfeld Business Overview

7.6.2 Biesterfeld Guaifenesin Quarterly Production and Revenue, 2020

7.6.3 Biesterfeld Guaifenesin Product Introduction

7.6.4 Biesterfeld Response to COVID-19 and Related Developments

7.7 Seven Star Pharma

7.7.1 Seven Star Pharma Business Overview

7.7.2 Seven Star Pharma Guaifenesin Quarterly Production and Revenue, 2020

7.7.3 Seven Star Pharma Guaifenesin Product Introduction

7.7.4 Seven Star Pharma Response to COVID-19 and Related Developments

7.8 Camlin Fine Science

7.8.1 Camlin Fine Science Business Overview

7.8.2 Camlin Fine Science Guaifenesin Quarterly Production and Revenue, 2020

7.8.3 Camlin Fine Science Guaifenesin Product Introduction

7.8.4 Camlin Fine Science Response to COVID-19 and Related Developments

7.9 Gennex Lab

7.9.1 Gennex Lab Business Overview

7.9.2 Gennex Lab Guaifenesin Quarterly Production and Revenue, 2020

7.9.3 Gennex Lab Guaifenesin Product Introduction

7.9.4 Gennex Lab Response to COVID-19 and Related Developments

7.10 Iwaki Seiyaku

7.10.1 Iwaki Seiyaku Business Overview

7.10.2 Iwaki Seiyaku Guaifenesin Quarterly Production and Revenue, 2020

7.10.3 Iwaki Seiyaku Guaifenesin Product Introduction

7.10.4 Iwaki Seiyaku Response to COVID-19 and Related Developments

7.11 Pan Drugs

7.11.1 Pan Drugs Business Overview

7.11.2 Pan Drugs Guaifenesin Quarterly Production and Revenue, 2020

7.11.3 Pan Drugs Guaifenesin Product Introduction

7.11.4 Pan Drugs Response to COVID-19 and Related Developments

7.12 Delta Synthetic

7.12.1 Delta Synthetic Business Overview

7.12.2 Delta Synthetic Guaifenesin Quarterly Production and Revenue, 2020

7.12.3 Delta Synthetic Guaifenesin Product Introduction

7.12.4 Delta Synthetic Response to COVID-19 and Related Developments

7.13 Smart Pharm

7.13.1 Smart Pharm Business Overview

7.13.2 Smart Pharm Guaifenesin Quarterly Production and Revenue, 2020

7.13.3 Smart Pharm Guaifenesin Product Introduction

7.13.4 Smart Pharm Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Guaifenesin Supply Chain Analysis

8.1.1 Guaifenesin Supply Chain Analysis

8.1.2 Covid-19 Impact on Guaifenesin Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Guaifenesin Distribution Channels

8.2.2 Covid-19 Impact on Guaifenesin Distribution Channels

8.2.3 Guaifenesin Distributors

8.3 Guaifenesin Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Guaifenesin Assessment

Table 9. COVID-19 Impact: Guaifenesin Market Trends

Table 10. COVID-19 Impact Global Guaifenesin Market Size

Table 11. Global Guaifenesin Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)

Table 12. Global Guaifenesin Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)

Table 13. Global Guaifenesin Quarterly Market Size, 2020 (US$ Million) & (K MT)

Table 14. Global Guaifenesin Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Guaifenesin Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)

Table 16. Global Guaifenesin Market Growth Drivers

Table 17. Global Guaifenesin Market Restraints

Table 18. Global Guaifenesin Market Opportunities

Table 19. Global Guaifenesin Market Challenges

Table 20. Key Manufacturers Guaifenesin Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Guaifenesin Market Size, 2019 (K MT) & (US$ Million)

Table 22. Guaifenesin Factory Price by Manufacturers 2020 (USD/MT)

Table 23. Location of Key Manufacturers Guaifenesin Manufacturing Plants

Table 24. Key Manufacturers Guaifenesin Market Served

Table 25. Date of Key Manufacturers Enter into Guaifenesin Market

Table 26. Key Manufacturers Guaifenesin Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Guaifenesin Market Size by Type, 2020, (US$ Million)

Table 29. Global Guaifenesin Market Size by Type, 2020 (K MT)

Table 30. Global Guaifenesin Price: by Type, 2020-2021 (USD/MT)

Table 31. Global Guaifenesin Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Guaifenesin Market Size by Application, 2020-2021 (K MT)

Table 33. Global Guaifenesin Price: by Application, 2020-2021 (USD/MT)

Table 34. Global Guaifenesin Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Guaifenesin Market Size by Region, 2019-2021 (K MT)

Table 36. By Country, North America Guaifenesin Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Guaifenesin Market Size, 2019-2021 (K MT)

Table 38. US Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 39. Canada Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Guaifenesin Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Guaifenesin Market Size, 2019-2021 (K MT)

Table 43. Germany Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 44. France Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 45. UK Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 46. Italy Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Guaifenesin Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Guaifenesin Market Size, 2019-2021 (K MT)

Table 50. China Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 51. Japan Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 52. South Korea Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 53. India Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 54. ASEAN Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 55. Latin America Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 56. Middle East and Africa Guaifenesin Market Size, 2019-2021 (US$ Million) & (K MT)

Table 57. Granules Business Overview

Table 58. Granules Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Granules Guaifenesin Product

Table 60. Granules Response to COVID-19 and Related Developments

Table 61. Synthokem Labs Business Overview

Table 62. Synthokem Labs Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Synthokem Labs Guaifenesin Product

Table 64. Synthokem Labs Response to COVID-19 and Related Developments

Table 65. Haizhou Pharma Business Overview

Table 66. Haizhou Pharma Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Haizhou Pharma Guaifenesin Product

Table 68. Haizhou Pharma Response to COVID-19 and Related Developments

Table 69. Yuan Cheng Group Business Overview

Table 70. Yuan Cheng Group Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Yuan Cheng Group Guaifenesin Product

Table 72. Yuan Cheng Group Response to COVID-19 and Related Developments

Table 73. Stellar Chemical Business Overview

Table 74. Stellar Chemical Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Stellar Chemical Guaifenesin Product

Table 76. Stellar Chemical Response to COVID-19 and Related Developments

Table 77. Biesterfeld Business Overview

Table 78. Biesterfeld Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Biesterfeld Guaifenesin Product

Table 80. Biesterfeld Response to COVID-19 and Related Developments

Table 81. Seven Star Pharma Business Overview

Table 82. Seven Star Pharma Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Seven Star Pharma Guaifenesin Product

Table 84. Seven Star Pharma Response to COVID-19 and Related Developments

Table 85. Camlin Fine Science Business Overview

Table 86. Camlin Fine Science Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Camlin Fine Science Guaifenesin Product

Table 88. Camlin Fine Science Response to COVID-19 and Related Developments

Table 89. Gennex Lab Business Overview

Table 90. Gennex Lab Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Gennex Lab Guaifenesin Product

Table 92. Gennex Lab Response to COVID-19 and Related Developments

Table 93. Iwaki Seiyaku Business Overview

Table 94. Iwaki Seiyaku Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Iwaki Seiyaku Guaifenesin Product

Table 96. Iwaki Seiyaku Response to COVID-19 and Related Developments

Table 97. Pan Drugs Business Overview

Table 98. Pan Drugs Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Pan Drugs Guaifenesin Product

Table 100. Pan Drugs Response to COVID-19 and Related Developments

Table 101. Delta Synthetic Business Overview

Table 102. Delta Synthetic Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Delta Synthetic Guaifenesin Product

Table 104. Delta Synthetic Response to COVID-19 and Related Developments

Table 105. Smart Pharm Business Overview

Table 106. Smart Pharm Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. Smart Pharm Guaifenesin Product

Table 108. Smart Pharm Response to COVID-19 and Related Developments

Table 109. Guaifenesin Distributors List

Table 110. Guaifenesin Customers List

Table 111. Covid-19 Impact on Guaifenesin Customers

List of Figures

Figure 1. Guaifenesin Product Picture

Figure 2. Guaifenesin Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Guaifenesin Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Guaifenesin Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Guaifenesin Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Guaifenesin Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Guaifenesin Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Guaifenesin Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Guaifenesin Market Size Market Share, 2019-2021

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950